IUPAC/Chemical Name
Glycine, N-(N-(aminoiminomethyl)-L-2-(3,5-dihydroxy-4-(1-methylethyl)phenyl)glycyl)-
InChi Key
QMFJWJLPWNAZMH-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H20N4O5/c1-6(2)11-8(19)3-7(4-9(11)20)12(18-14(15)16)13(23)17-5-10(21)22/h3-4,6,12,19-20H,5H2,1-2H3,(H,17,23)(H,21,22)(H4,15,16,18)
SMILES Code
O=C(O)CNC(C(C1=CC(O)=C(C(C)C)C(O)=C1)NC(N)=N)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
324.34
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Masaki S, Konishi T, Tsuji N, Shoji J. New antibiotics, resorcinomycins A and B: antibacterial activity of resorcinomycin A against mycobacteria in vitro. J Antibiot (Tokyo). 1989 Mar;42(3):463-6. doi: 10.7164/antibiotics.42.463. PMID: 2708139.
2: Gomez-Flores R, Hsia R, Tamez-Guerra R, Mehta RT. Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation. Antimicrob Agents Chemother. 1996 Nov;40(11):2545-9. doi: 10.1128/AAC.40.11.2545. PMID: 8913461; PMCID: PMC163572.
3: Ooya K, Ogasawara Y, Noike M, Dairi T. Identification and analysis of the resorcinomycin biosynthetic gene cluster. Biosci Biotechnol Biochem. 2015;79(11):1833-7. doi: 10.1080/09168451.2015.1050992. Epub 2015 Jun 2. PMID: 26034896.
4: Ogasawara Y, Ooya K, Fujimori M, Noike M, Dairi T. Structure and activity relationships of the anti-Mycobacterium antibiotics resorcinomycin and pheganomycin. J Antibiot (Tokyo). 2016 Feb;69(2):119-20. doi: 10.1038/ja.2015.88. Epub 2015 Aug 26. PMID: 26306817.
5: Gomez-Flores R, Gupta S, Tamez-Guerra R, Mehta RT. Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J Clin Microbiol. 1995 Jul;33(7):1842-6. doi: 10.1128/JCM.33.7.1842-1846.1995. PMID: 7665657; PMCID: PMC228282.
6: Mehta RT, Keyhani A, McQueen TJ, Rosenbaum B, Rolston KV, Tarrand JJ. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob Agents Chemother. 1993 Dec;37(12):2584-7. doi: 10.1128/aac.37.12.2584. PMID: 8109920; PMCID: PMC192745.
7: Kondo E, Katayama T, Kawamura Y, Yasuda Y, Matsumoto K, Ishii K, Tanimoto T, Hinoo H, Kato T, Kyotani H, et al. Isolation and characterization of new antibiotics resorcinomycins A and B. J Antibiot (Tokyo). 1989 Jan;42(1):1-6. doi: 10.7164/antibiotics.42.1. PMID: 2921214.
